Elekta (STO:EKTA B) said today it won a supply agreement with the Stockholm County Council to supply equipment to its flagship New Karolinska Solna hospital. The company said it expects the deal to be formally signed during its the 1st quarter of fiscal year 2016/2017, with the bulk of installations scheduled for April 2017. “As a […]
Humediq wins $9.9m in spat with Elekta
Elekta (STO:EKTA B) said today that an arbitration tribunal in London this week found in favor of Humediq to the tune of $9.9 million (EU €8.9 million) in a spat with 2 Elekta subsidiaries over exclusive supply agreements. The dispute is over an agreement Elekta entered into in 2011 in which it became the exclusive supplier of […]
Elekta inks $100m deal Down Under
Elekta (STO:EKTA B) said yesterday it inked an 8-year strategic partnership with Australian radiotherapy provider GenesisCare for more than $100m. The new partnership includes the acquisition of Elekta’s Leksell Gamma Knife Icon radiosurgery systems, Versa HD linear accelerators, brachytherapy systems, software and other services, Elekta said. “We are proud to partner alongside GenesisCare and support their […]
ITC grants Varian bid for Elekta investigation
The U.S. International Trade Commission said last week that it will begin an investigation into alleged Tariff Act violations by Elekta (STO:EKTA B), based on a complaint by arch-rival Varian Medical (NYSE:VAR). Varian makes the TruBeam and VitalBeam radiotherapy systems, which compete with Elekta’s Versa HD and Infinity devices. The ITC said Oct. 26 that it would […]
Elekta wins FDA nod for next-gen Gamma Knife
Elekta (STO:EKTA B) said Wednesday it won FDA 510(k) clearance for its next-generation Gamma Knife Icon radiosurgery system. The Icon is Elekta’s 6th generation radiosurgery system, which uses low-intensity radiation as an alternative to traditional brain surgery, the Atlanta, Ga.-based company said. “Leksell Gamma Knife Icon offers a new model for the application of precise radiosurgery for […]
Elekta sacks CEO Savander on 2014 sales plunge, shares plummet
Medtech’s $33m lobbying spend last year hits 16-year high
The medical device industry’s lobbying spend hit its highest point since 1998 last year, nearing $33 million, as the industry stepped up its campaign to repeal the medical device tax enacted as part of Obamacare.
Cook Medical promotes Creissel to urology veep | Personnel Moves
Cook Medical said it promoted Jean-Marc Creissel to vice president of its urology business, which Creissel has led since 2010.
Medtronic shareholder sues to block pending merger with Covidien | The week in medtech M&A
Elekta eyes Turkish radiology market with acquisition of Mesi Medikal
